Crescita Therapeutics Inc. (TSX: CTX)
0.640
+0.010 (1.59%)
Aug 22, 2024, 1:48 PM EDT
Crescita Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Cash & Equivalents | 9.01 | 9.39 | 8.24 | 11.33 | 14.28 | 9.27 | Upgrade
|
Short-Term Investments | - | 0 | 0.07 | 0.08 | 0.06 | 0.06 | Upgrade
|
Cash & Short-Term Investments | 9.01 | 9.39 | 8.31 | 11.41 | 14.34 | 9.33 | Upgrade
|
Cash Growth | -11.87% | 12.97% | -27.17% | -20.44% | 53.74% | 7.97% | Upgrade
|
Accounts Receivable | 2.3 | 2.75 | 6.14 | 3.6 | 1.22 | 2.51 | Upgrade
|
Other Receivables | - | 0.02 | 0.1 | 0.15 | 0.2 | 0.08 | Upgrade
|
Receivables | 2.3 | 2.78 | 6.24 | 3.75 | 1.42 | 2.58 | Upgrade
|
Inventory | 5.27 | 6.13 | 5.65 | 4.39 | 3.46 | 3.78 | Upgrade
|
Prepaid Expenses | - | 0.2 | 0.32 | 0.54 | 0.24 | 0.23 | Upgrade
|
Other Current Assets | 0.45 | - | - | - | - | - | Upgrade
|
Total Current Assets | 17.04 | 18.49 | 20.52 | 20.09 | 19.45 | 15.92 | Upgrade
|
Property, Plant & Equipment | 1.66 | 1.85 | 2.31 | 2.58 | 0.79 | 1.18 | Upgrade
|
Long-Term Investments | 0.35 | 0.36 | 0.34 | 0.34 | - | - | Upgrade
|
Other Intangible Assets | 2.03 | 1.99 | 2.87 | 3.74 | 4.61 | 7.57 | Upgrade
|
Long-Term Accounts Receivable | 1.43 | 1.48 | 1.57 | 1.66 | 1.98 | 1.58 | Upgrade
|
Long-Term Deferred Tax Assets | - | - | 0.46 | - | - | 0.58 | Upgrade
|
Total Assets | 22.95 | 24.6 | 28.48 | 28.92 | 26.83 | 26.84 | Upgrade
|
Accounts Payable | 4.56 | 4.33 | 5.59 | 5.33 | 4.27 | 3.93 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 0.98 | - | - | Upgrade
|
Current Portion of Leases | 0.45 | 0.44 | 0.41 | 0.37 | 0.3 | 0.36 | Upgrade
|
Other Current Liabilities | 0.05 | 0.1 | 0.06 | 0.06 | 0.05 | 0.05 | Upgrade
|
Total Current Liabilities | 5.06 | 4.86 | 6.06 | 6.73 | 4.62 | 4.34 | Upgrade
|
Long-Term Debt | - | - | - | - | 0.93 | 0.9 | Upgrade
|
Long-Term Leases | 0.59 | 0.82 | 1.21 | 1.53 | - | 0.3 | Upgrade
|
Other Long-Term Liabilities | 0.11 | 0.1 | 0.12 | 0.15 | 0.15 | 0.2 | Upgrade
|
Total Liabilities | 5.76 | 5.78 | 7.39 | 8.4 | 5.7 | 5.73 | Upgrade
|
Common Stock | 53.6 | 54.34 | 56.3 | 58.08 | 58.18 | 58.42 | Upgrade
|
Additional Paid-In Capital | 6.63 | 5.96 | 4.27 | 2.77 | 2.27 | 1.95 | Upgrade
|
Retained Earnings | -44.15 | -42.6 | -40.61 | -41.48 | -40.37 | -40.41 | Upgrade
|
Comprensive Income & Other | 1.12 | 1.12 | 1.13 | 1.15 | 1.05 | 1.15 | Upgrade
|
Shareholders' Equity | 17.2 | 18.82 | 21.1 | 20.53 | 21.13 | 21.11 | Upgrade
|
Total Liabilities & Equity | 22.95 | 24.6 | 28.48 | 28.92 | 26.83 | 26.84 | Upgrade
|
Total Debt | 1.04 | 1.25 | 1.61 | 2.87 | 1.23 | 1.55 | Upgrade
|
Net Cash (Debt) | 7.98 | 8.13 | 6.7 | 8.54 | 13.11 | 7.78 | Upgrade
|
Net Cash Growth | -9.50% | 21.46% | -21.60% | -34.85% | 68.51% | 83.90% | Upgrade
|
Net Cash Per Share | 0.40 | 0.40 | 0.32 | 0.41 | 0.63 | 0.35 | Upgrade
|
Filing Date Shares Outstanding | 19.38 | 19.54 | 20.33 | 20.9 | 20.62 | 20.71 | Upgrade
|
Total Common Shares Outstanding | 19.41 | 19.96 | 20.33 | 20.98 | 20.65 | 20.74 | Upgrade
|
Working Capital | 11.97 | 13.62 | 14.46 | 13.37 | 14.84 | 11.58 | Upgrade
|
Book Value Per Share | 0.89 | 0.94 | 1.04 | 0.98 | 1.02 | 1.02 | Upgrade
|
Tangible Book Value | 15.16 | 16.83 | 18.23 | 16.79 | 16.52 | 13.54 | Upgrade
|
Tangible Book Value Per Share | 0.78 | 0.84 | 0.90 | 0.80 | 0.80 | 0.65 | Upgrade
|
Machinery | - | 2.68 | 2.56 | 2.32 | 1.97 | 1.92 | Upgrade
|
Leasehold Improvements | - | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.